Compare · LNSR vs MDLN
LNSR vs MDLN
Side-by-side comparison of LENSAR Inc. (LNSR) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LNSR and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 649.0x LNSR ($74.1M).
- Over the past year, LNSR is down 52.3% and MDLN is down 11.8% - MDLN leads by 40.6 points.
- MDLN has hit the wire 7 times in the past 4 weeks while LNSR has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 3 for LNSR).
PerformanceLNSR-51.05%MDLN-11.77%
2025-12-17+0.00%2026-10-16
- Company
- LENSAR Inc.
- Medline Inc.
- Price
- $5.82-3.96%
- $35.95-1.74%
- Market cap
- $74.1M
- $48.08B
- 1M return
- -18.26%
- +11.97%
- 1Y return
- -52.33%
- -11.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 0
- 7
- Recent ratings
- 3
- 25
LNSR
LENSAR Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Latest LNSR
- SEC Form 10-Q filed by LENSAR Inc.
- LENSAR Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
- LENSAR Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026
- SEC Form DEFA14A filed by LENSAR Inc.
- SEC Form DEF 14A filed by LENSAR Inc.
- Director Hammer Todd B was granted 17,421 shares, increasing direct ownership by 45% to 56,083 units (SEC Form 4)
- Director Ellis Thomas B was granted 17,421 shares, increasing direct ownership by 45% to 56,083 units (SEC Form 4)
- Principal Accounting Officer Wong Kendra was granted 13,066 shares, increasing direct ownership by 30% to 56,481 units (SEC Form 4)
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M